Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the ...

On June 17, 2024, the U.S. Food and Drug Administration (FDA) licensed Merck & Company, Inc.'s new pneumococcal conjugate vaccine Capvaxive (formerly ...

Public health officials in Finland are preparing to offer H5N1 influenza (also known as avian influenza or bird flu) vaccines to people ...

According to a new study published in Nature Microbiology, babies born via Caesarean section (C-section) are likely to fail to respond to ...

Moderna, Inc. announced recently that it has suspended its efforts to build a $200–$500 million mRNA (messenger ribonucleic acid) biologics manufacturing facility ...

On May 10, 2024, the World Health Organization (WHO) granted prequalification status to the Qdenga (TAK-003) dengue vaccine, developed by Takeda Pharmaceutical ...

Francois-Xavier Fumu Tamuzo, former French U20 player, is suing Pfizer-Germany, Pfizer-France, BioNTech and the French Football Federation (FFF) for injuries he said ...

A new mRNA cancer biological labeled a “vaccine" is showing promise in treating an aggressive type of brain cancer called glioblastoma. The ...